Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Robertson

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Pharmacology, Biochemistry, and Behavior|July 1, 1988
Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus releaseR W Fuller, H D Snoddy, D W Robertson
European Journal of Pharmacology|July 4, 1989
Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortexD T Wong, D W Robertson, L R Reid
Research Communications in Chemical Pathology and Pharmacology|April 1, 1992
Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in ratsR W Fuller, H D Snoddy, D W Robertson
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1989
Electrophysiological effects of flecainide enantiomers in canine Purkinje fibresJ K Smallwood, D W Robertson, M I Steinberg
Circulation Research|July 1, 1989
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranesR F Kauffman, B G Utterback, D W Robertson
Neuroscience Letters|July 23, 1993
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sitesD R Gehlert, S L Gackenheimer, D W Robertson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1991
Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptorsD T Wong, P G Threlkeld, D W Robertson
Circulation Research|May 1, 1989
Specific binding of [3H]LY186126, an analogue of indolidan (LY195115), to cardiac membranes enriched in sarcoplasmic reticulum vesiclesR F Kauffman, B G Utterback, D W Robertson
Research Communications in Chemical Pathology and Pharmacology|October 1, 1985
Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletorsR W Fuller, S K Hemrick-Luecke, D W Robertson
Biochemical Pharmacology|September 1, 1988
Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrineR W Fuller, S K Hemrick-Luecke, D W Robertson
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Pharmacology, Biochemistry, and Behavior|July 1, 1988
Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus releaseR W Fuller, H D Snoddy, D W Robertson
European Journal of Pharmacology|July 4, 1989
Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortexD T Wong, D W Robertson, L R Reid
Research Communications in Chemical Pathology and Pharmacology|April 1, 1992
Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in ratsR W Fuller, H D Snoddy, D W Robertson
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1989
Electrophysiological effects of flecainide enantiomers in canine Purkinje fibresJ K Smallwood, D W Robertson, M I Steinberg
Circulation Research|July 1, 1989
Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranesR F Kauffman, B G Utterback, D W Robertson
Neuroscience Letters|July 23, 1993
Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sitesD R Gehlert, S L Gackenheimer, D W Robertson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1991
Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptorsD T Wong, P G Threlkeld, D W Robertson
Circulation Research|May 1, 1989
Specific binding of [3H]LY186126, an analogue of indolidan (LY195115), to cardiac membranes enriched in sarcoplasmic reticulum vesiclesR F Kauffman, B G Utterback, D W Robertson
Research Communications in Chemical Pathology and Pharmacology|October 1, 1985
Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletorsR W Fuller, S K Hemrick-Luecke, D W Robertson
Biochemical Pharmacology|September 1, 1988
Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrineR W Fuller, S K Hemrick-Luecke, D W Robertson
Pageof 9